CIK 0001563880
- Non-accelerated filer
- Smaller reporting company
Trevi Therapeutics, Inc.
Sign in to watch- Ticker
- TRVI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 450834299
- Phone
- +1 203-304-2499
- Business address
- 195 CHURCH STREET, 16TH FLOOR, NEW HAVEN, CT, 06510
- 4 Open-market sale Chief Financial Officer sold 4,350 shares at $2.64 ($11,485)
- 4 Open-market sale President & CEO sold 25,037 shares at $2.86 ($71,576)
- 4 Open-market sale President & CEO sold 4,578 shares at $2.90 ($13,276)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Planned sale Chief Financial Officer sold 785 shares at $2.02 ($1,586)
- 4 Planned sale Chief Financial Officer sold 711 shares at $2.20 ($1,564)
- 4 Planned sale Chief Financial Officer sold 682 shares at $2.36 ($1,610)
- 4 Planned sale Chief Financial Officer sold 687 shares at $2.34 ($1,608)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion Chief Commercial Officer acquired 6,250 shares (option exercise)
Page 4 of 13 · 257 filings